Upregulation of Apolipoprotein L6 Improves Tumor Immunotherapy by Inducing Immunogenic Cell Death

In the past few years, immune checkpoint blockade (ICB) therapy has emerged as a breakthrough treatment for cancers and has demonstrated inspiring effects in tumor patients with Epstein-Barr virus (EBV) infection. To allow more patients to benefit from immunotherapy, exploring novel biomarkers based...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Kecheng, Chen, Yutong, Li, Bixiang, Li, Yaning, Liang, Xinyue, Lin, Hai, Luo, Lisi, Chen, Tianliang, Dai, Yalan, Pang, Wenzheng, Zeng, Linjuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046184/
https://www.ncbi.nlm.nih.gov/pubmed/36979348
http://dx.doi.org/10.3390/biom13030415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046184/
https://www.ncbi.nlm.nih.gov/pubmed/36979348
http://dx.doi.org/10.3390/biom13030415

Ejemplares similares